Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bionor Pharma ASA
DescriptionHumoral vaccine based on modified synthetic peptides from the C5 area of gp 120
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationHIV / AIDS
Indication DetailsTreat and prevent HIV/AIDS infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today